Evaluation of Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy
Authors:
- Dilraj S. GrewalDGDilraj S. Grewal
- Rajeev JainRJRajeev Jain
- Harsh KumarHKHarsh Kumar
- Satinder Pal Singh GrewalSGSatinder Pal Singh Grewal
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 115 (12) , 2141-2145.e2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Potential Role of Rho-Associated Protein Kinase Inhibitor Y-27632 in Glaucoma Filtration SurgeryInvestigative Ophthalmology & Visual Science, 2007
- Role of Intravitreal Bevacizumab in Neovascular GlaucomaJournal of Ocular Pharmacology and Therapeutics, 2007
- Intravitreal Bevacizumab (Avastin) Injection for Neovascular GlaucomaJournal of Glaucoma, 2007
- Intravitreal Bevacizumab for Filtering SurgeryOphthalmic Research, 2007
- VITREOUS LEVELS OF UNBOUND BEVACIZUMAB AND UNBOUND VASCULAR ENDOTHELIAL GROWTH FACTOR IN TWO PATIENTSRetina, 2006
- Intracameral Bevacizumab for Iris RubeosisAmerican Journal of Ophthalmology, 2006
- VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B–PDGFRβ signalingJournal of Cell Science, 2005
- Alkylphosphocholines: A New Therapeutic Option in Glaucoma Filtration SurgeryInvestigative Ophthalmology & Visual Science, 2004
- Defining "occludable" angles in population surveys: drainage angle width, peripheral anterior synechiae, and glaucomatous optic neuropathy in east Asian peopleBritish Journal of Ophthalmology, 2004
- Discordant effects of a soluble VEGF receptor on wound healing and angiogenesisGene Therapy, 2004